<DOC>
	<DOCNO>NCT01376570</DOCNO>
	<brief_summary>This study test whether contingency management ( monetary voucher contingent abstinence drug ) reinforce one behavior ( achieve abstinence drug ) lead improved outcome related behavior ( achieve HIV viral load suppression ) . In randomized controlled trial , investigator propose test whether abstinence-reinforcing contingency management intervention improve viral load suppression HIV-infected drug user .</brief_summary>
	<brief_title>Project FIRST - Financial Incentives Reduce Substance Use Improve Treatment</brief_title>
	<detailed_description>Using randomize control study design , investigator test efficacy abstinence-reinforcing contingency management intervention compare control condition ( Performance Feedback ) HIV viral load suppression . The investigator enroll 202 opioid-dependent HIV-infected individual receive opioid agonist treatment buprenorphine methadone , continue use opiate , oxycodone cocaine ( drug consistently associate poor HIV treatment outcome ) , prescribed antiretroviral medication , suboptimal viral load suppression . The contingency management group potential receive $ 1320 voucher 16-week intervention base drug-free urine . Participants follow 28 week , research visit occur twice weekly Baseline Period ( week 1-4 ) Intervention Period ( week 5-20 ) , every two week Post-Intervention Period ( week 21-28 ) . Data source include blood test ( viral load CD4 count ) , urine toxicology test , questionnaire , pill count , medical record . The primary outcome change HIV viral load , secondary outcome include CD4 count , antiretroviral adherence , abstinence .</detailed_description>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<criteria>least 18 year old English Spanish fluency HIVinfected Currently take highly active antiretroviral therapy ) opioid use disorder receive opioid agonist treatment methadone buprenorphine , b ) cocaine use disorder urine toxicology positive cocaine , oxycodone , opioids runin period detectable viral load prescribe highly active antiretroviral therapy prior 6 month selfreported adherence HAART &lt; 100 % inability give inform consent inability follow research protocol ( e.g. , visit twice weekly ) frequent hospitalization ( &gt; 2 ) prior 6 month currently chronic pain condition participant prescribe opioid analgesic longer past month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>HIV</keyword>
	<keyword>Opiate dependence</keyword>
	<keyword>Opiate replacement therapy</keyword>
	<keyword>Cocaine-related disorder</keyword>
	<keyword>Risk Reduction Behavior</keyword>
	<keyword>Medication Adherence</keyword>
	<keyword>Motivation</keyword>
</DOC>